Midwest Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,853
Closed -$252K 624
2026
Q1
$252K Sell
6,853
-352
-5% -$16.7K ﹤0.01% 542
2025
Q4
$367K Sell
7,205
-1,051
-13% -$53.7K ﹤0.01% 471
2025
Q3
$458K Sell
8,256
-424
-5% -$24.8K 0.01% 436
2025
Q2
$599K Buy
+8,680
New +$590K 0.01% 398

Other funds holding NVO

Midwest Trust's NVO Position: Q2 2026 in Review

Midwest Trust sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 6,853 shares — an estimated $252K sold.

Midwest Trust first reported a position in NVO in Q2 2025 and held it in 4 quarters. The position peaked at $599K in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Midwest Trust reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Midwest Trust sold 6,853 Novo Nordisk shares in Q2 2026, an estimated $252K.
  • Midwest Trust first reported a position in Novo Nordisk in Q2 2025 and held it in 4 quarters.
  • Midwest Trust's Novo Nordisk position peaked at $599K in Q2 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.